Riskpilot← Back to searchSign inGet full accessSnippologica AB
ABActiveOrg 5592599749Warfvinges Väg 18 Lgh 2132Hospital activities · NACE 8610Est. 20200 employees
Revenue 2025
SEK 43K
-10% vs 2024
EBITDA margin
14.0%
-14% vs 2024
Equity ratio
69.6%
Financial strength
Net profit 2025
SEK 5K
-17% vs 2024
| Revenue | SEK 43K | -10% |
| EBITDA | SEK 6K | -14% |
| Net profit | SEK 5K | -17% |
| Total assets | SEK 161K | +4% |
| Equity | SEK 112K | +5% |
| Employees | 0 | — |
Legal name
Snippologica AB
Org number
5592599749
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
16 juni 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva vård, konsultation samt utbildning inom hälsa, kvinnohälsa, psykologi, själslig vård samt närliggande discipliner, verksamhet inom friskvård, företagshälsovård, träning, gym, arbetsmiljö, kroppsvård, rehabilitering, sjukgymnastik, beteendevetenskap, kurser och föreläsningar, personlig utveckling, behandlingar, yoga, dans, stressreducering, meditation, avslappning och mindfulness. Bolaget skall också förvalta värdepapper och därmed förenlig verksamhet.
Address
Warfvinges Väg 18 Lgh 2132
Email
elisabeth.vock@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 204 | 0 | 45 | 48 | 43 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 107 | −13 | 17 | 7 | 6 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 107 | −13 | 17 | 7 | 6 |
| Net financials | — | — | — | — | 1 |
| Profit before tax | 80 | 0 | 18 | 7 | 6 |
| Tax | −17 | −0 | −4 | −1 | −1 |
| Net profit | 63 | 0 | 14 | 6 | 5 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 205 | 150 | 145 | 155 | 161 |
| Equity | 88 | 88 | 101 | 107 | 112 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 90 | 48 | 29 | 34 | 35 |
| Total debt | 90 | 48 | 29 | 34 | 35 |
EBITDA margin
14.0%
This company
15.8%
Market median
-11% vs market
20212025
Equity ratio
69.6%
This company
38.2%
Market median
+82% vs market
20212025
Return on equity
4.5%
This company
18.4%
Market median
-76% vs market
20212025
Net profit margin
11.6%
This company
8.1%
Market median
+43% vs market
20212025
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20212025
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-06-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Snippologica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingrid Elisabeth Vock | Board of Directors | 0 companies |
| Johannes Helmer Vock | Deputy Board Member | 0 companies |